PLUS THERAPEUTICS, INC. — Director's Dealing 2011

May 2, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTORI THERAPEUTICS, INC. (CYTX)
CIK: 0001095981
Period of Report: 2011-04-28

Reporting Person: Dean Lloyd H (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-04-28	Non-Qualified Stock Option (Right to Buy)	$7.34	A	5000	Acquired	2021-04-28	Common Stock (5000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Restricted Stock Award	21000	Direct

Footnotes

F1: The option vests monthly over two years, subject to Mr. Dean's continued service to the Company.